Skip to main content

CombiMatrix to Receive $4.9M from Private Placement

NEW YORK, May 20 - CombiMatrix parent Acacia Research announced a private placement of 2.4 million units of its common stock today, out of which CombiMatrix will receive about $4.9 million.

 

The stock units, which include one share of Acacia Research-CombiMatrix stock and one-half warrant, are being purchased for $2.20 per unit, for a total of $5.28 million.

 

The company plans to use its funding to give it "the flexibility to take advantage of current opportunities," CEO Amit Kumar said in a statement.

 

CombiMatrix, founded in 1995, was funded with $36 million in August 2000. Acacia Research, which has since bought a majority stake of the company's equity, was the lead investor in the VC funding, anteing in $17.5 million with additional investments from a mix of Silicon Valleyand New Yorkventure capital investors.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.